WHO Prequalifies Celltrion’s Rituximab

Truxima Becomes Second Biosimilar To Be Prequalified By Organization

 
• By David Wallace
  
WHO
The WHO has prequalified Celltrion’s Truxima rituximab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products